Fig. 6
From: Regulation of aging by balancing mitochondrial function and antioxidant levels
The combined use of FBX and sodium ascorbate treatment suppresses a phenotype of familial Parkinson’s disease in C. elegans. A FBX (0, 5, 10, and 20 µg/ml) and sodium ascorbate (Vit. C, 0, 4 mM) were added to Tg animals expressing α-synuclein (S129A) (tmIs913 [Punc-51::α-SynS129A]) and tmIs907 [Punc-51::EGFP] as a control. The body size was quantified at 96 h after bleaching. ****P < 0.0001. Number of trials and total number of animals are shown in Table 3. B Representative images of the body size